US FDA’s Cavazzoni To Manufacturers: Pay Attention To Data Received From CROs

 
• By Anju Ghangurde
The FDA flags concerns about data integrity issues at CROs • Source: Shutterstock

More from Regulation

More from Policy & Regulation